Drug safety. FDA panel urges caution on many anti-inflammatory drugs.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Publication: : Washington, DC : American Association for the Advancement of Science
Original Publication: New York, N.Y. : [s.n.] 1880-

Advisory Committees* ; Drug Labeling* ; United States Food and Drug Administration*; Cyclooxygenase Inhibitors/*adverse effects ; Cyclooxygenase Inhibitors/*therapeutic use; Anti-Inflammatory Agents, Non-Steroidal/adverse effects ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Cardiovascular Diseases/chemically induced ; Cardiovascular Diseases/epidemiology ; Celecoxib ; Drug and Narcotic Control ; Humans ; Isoxazoles/adverse effects ; Isoxazoles/therapeutic use ; Lactones/adverse effects ; Lactones/therapeutic use ; Pyrazoles/adverse effects ; Pyrazoles/therapeutic use ; Stroke/chemically induced ; Stroke/epidemiology ; Sulfonamides/adverse effects ; Sulfonamides/therapeutic use ; Sulfones/adverse effects ; Sulfones/therapeutic use ; United States

0 (Anti-Inflammatory Agents, Non-Steroidal)
0 (Cyclooxygenase Inhibitors)
0 (Isoxazoles)
0 (Lactones)
0 (Pyrazoles)
0 (Sulfonamides)
0 (Sulfones)
0QTW8Z7MCR (rofecoxib)
2919279Q3W (valdecoxib)
JCX84Q7J1L (Celecoxib)

Date Created: 20050226 Date Completed: 20050311 Latest Revision: 20151119

20231215

10.1126/science.307.5713.1183a

15731414